New Gene Therapy Study Results from French National Institute of Health and Medical Research UMR1163 Described [Adenine Base Editor-mediated Correction of the Common and Severe Ivs1-110 (G > A) Beta-thalassemia Mutation].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      Paris, France, Europe, Anemia, Bioengineering, Biotechnology, Congenital Anemia, Drugs and Therapies, Gene Therapy, Genetics, Health and Medicine, Hematologic Diseases and Conditions, Hematology, Hemic and Lymphatic Diseases and Conditions, Hemoglobinopathies, Hemolytic, Thalassemia, Beta Thalassemia Keywords: Paris; France; Europe; Anemia; Beta Thalassemia; Bioengineering; Biotechnology; Congenital Anemia; Drugs and Therapies; Gene Therapy; Genetics; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Hemic and Lymphatic Diseases and Conditions; Hemoglobinopathies; Hemolytic; Thalassemia EN Paris France Europe Anemia Beta Thalassemia Bioengineering Biotechnology Congenital Anemia Drugs and Therapies Gene Therapy Genetics Health and Medicine Hematologic Diseases and Conditions Hematology Hemic and Lymphatic Diseases and Conditions Hemoglobinopathies Hemolytic Thalassemia 945 945 1 07/24/23 20230724 NES 230724 2023 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Fresh data on Biotechnology - Gene Therapy are presented in a new report. [Extracted from the article]
    • Abstract:
      Copyright of Gene Therapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)